Diagnostic tests for human Schistosoma mansoni and Schistosoma haematobium infection: a systematic review and meta-analysis.
Journal article
Vaillant MT. et al, (2024), The Lancet. Microbe
Sex differences in post-acute neurological sequelae of SARS-CoV-2 and symptom resolution in adults after coronavirus disease 2019 hospitalization: an international multi-centre prospective observational study
Journal article
Cho S-M. et al, (2024), Brain Communications, 6
Systematic Review of Scales for Measuring Infectious Disease–Related Stigma
Journal article
Paterson A. et al, (2024), Emerging Infectious Diseases, 30
Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development.
Journal article
Castro MDM. et al, (2024), PLoS neglected tropical diseases, 18
Challenges in Clinical Diagnosis of Clade I Mpox: Highlighting the Need for Enhanced Diagnostic Approaches
Preprint
Bourner J. et al, (2024)
Experiences and challenges with the new European Clinical Trials Regulation.
Journal article
Patrick-Brown TDJH. et al, (2024), Trials, 25
Bubonic plague: can the size of buboes be accurately and consistently measured with a digital calliper?
Journal article
Bourner J. et al, (2023), Trials, 24
Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19.
Journal article
Camirand-Lemyre F. et al, (2023), JAMA network open, 6
Variability in clinical assessment of clade IIb mpox lesions
Journal article
Jones B. et al, (2023), International Journal of Infectious Diseases, 137, 60 - 62
Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study.
Journal article
Reyes LF. et al, (2023), Journal of critical care, 77
Laboratory Diagnosis of Mpox, Central African Republic, 2016-2022.
Journal article
Garba-Ouangole S. et al, (2023), Emerging infectious diseases, 29, 1846 - 1849
A Randomized Trial to Assess the Impact of a Package of Diagnostic Tools and Diagnostic Algorithm on Antibiotic Prescriptions for the Management of Febrile Illnesses Among Children and Adolescents in Primary Health Facilities in Burkina Faso
Journal article
Kiemde F. et al, (2023), Clinical Infectious Diseases, 77, S134 - S144
Impact of Point-of-Care Rapid Diagnostic Tests on Antibiotic Prescription Among Patients Aged <18 Years in Primary Healthcare Settings in 2 Peri-Urban Districts in Ghana: Randomized Controlled Trial Results
Journal article
Adjei A. et al, (2023), Clinical Infectious Diseases, 77, S145 - S155
Impact of the Introduction of a Package of Diagnostic Tools, Diagnostic Algorithm, and Training and Communication on Outpatient Acute Fever Case Management at 3 Diverse Sites in Uganda: Results of a Randomized Controlled Trial
Journal article
Kapisi J. et al, (2023), Clinical Infectious Diseases, 77, S156 - S170
A Qualitative Assessment of a Training and Communication Intervention on Antibiotic Prescription Practices Among Health Workers and Outpatients at Public Health Facilities in Uganda.
Journal article
Kaawa-Mafigiri D. et al, (2023), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 77, S191 - S198
Breakthrough treatments for Ebola virus disease, but no access-what went wrong, and how can we do better?
Journal article
Torreele E. et al, (2023), The Lancet. Infectious diseases, 23, e253 - e258
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry.
Journal article
Griffee MJ. et al, (2023), Research and practice in thrombosis and haemostasis, 7
Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19.
Journal article
Wainstein M. et al, (2023), Kidney international reports
On the importance and challenges of global access to proven life-saving treatments for Ebolavirus - Authors' reply.
Journal article
Torreele E. et al, (2023), The Lancet. Infectious diseases, 23, 407 - 408
The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs.
Journal article
Farlow A. et al, (2023), Vaccines (Basel), 11
[MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks].
Journal article
Kali S. et al, (2023), Virologie (Montrouge, France), 27, 23 - 26
Malaria patient spectrum representation in therapeutic clinical trials of uncomplicated malaria: a scoping review of the literature.
Journal article
Arena L. et al, (2023), Malaria journal, 22
MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks.
Journal article
Kali S. et al, (2023), Virologie (Montrouge, France), 27, 12 - 15
A legacy of progress in clinical pharmacology and social justice; remembering Peter Ian Folb.
Journal article
Barnes KI. et al, (2023), Bulletin of the World Health Organization, 101, 3 - 3A
Involving patients in drug development for neglected tropical diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into target product profile development
Conference paper
Erber A. et al, (2023), TROPICAL MEDICINE & INTERNATIONAL HEALTH, 28, 387 - 387
Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core Outcome Set development
Journal article
Munblit D. et al, (2022), BMC Medicine, 20
Tecovirimat for Monkeypox in Central African Republic under Expanded Access.
Journal article
Mbrenga F. et al, (2022), The New England journal of medicine, 387, 2294 - 2295
Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis
Journal article
Dahal P. et al, (2022), Malaria Journal, 21
Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients
Journal article
Baruch J. et al, (2022), Influenza and Other Respiratory Viruses, 16, 1040 - 1050
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients.
Journal article
Gonçalves BP. et al, (2022), eLife, 11
Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity.
Journal article
Marwali EM. et al, (2022), BMJ paediatrics open, 6
Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study
Journal article
Reyes LF. et al, (2022), Critical Care, 26
Monkeypox: how will we know if the treatments work?
Journal article
Rojek A. et al, (2022), The Lancet. Infectious diseases, 22, 1269 - 1270
Characterising Long Covid: a living systematic review update with controlled studies
Preprint
Michelen M. et al, (2022)
Monkeypox treatment with tecovirimat in the Central African Republic under an Expanded Access Programme
Preprint
Mbrenga F. et al, (2022)
Egg excretion indicators for the measurement of soil-transmitted helminth response to treatment.
Journal article
Olliaro PL. et al, (2022), PLoS neglected tropical diseases, 16
Response to Visceral Leishmaniasis Cases through Active Case Detection and Vector Control in Low-Endemic Hilly Districts of Nepal.
Journal article
Banjara MR. et al, (2022), The American journal of tropical medicine and hygiene, 107, 349 - 354
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
Journal article
Abbas A. et al, (2022), Scientific Data, 9
Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID).
Journal article
Pazukhina E. et al, (2022), BMC medicine, 20
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study.
Journal article
Munblit D. et al, (2022), The Lancet. Respiratory medicine, 10, 715 - 724
Long COVID: aiming for a consensus.
Journal article
Munblit D. et al, (2022), The Lancet. Respiratory medicine, 10, 632 - 634
Symptom-based case definitions for COVID-19: time and geographical variations for detection at hospital admission among 260,000 patients
Preprint
Group ISARICCC. et al, (2022)
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
Journal article
Knight SR. et al, (2022), Thorax, 77, 606 - 615
Waking up to monkeypox.
Journal article
Nakoune E. and Olliaro P., (2022), BMJ (Clinical research ed.), 377
Global challenges in preparedness and response to epidemic infectious diseases.
Journal article
Olliaro P. and Torreele E., (2022), Molecular therapy : the journal of the American Society of Gene Therapy, 30, 1801 - 1809
Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing
Journal article
Salam AP. et al, (2022), PLOS Neglected Tropical Diseases, 16, e0010289 - e0010289
Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
Journal article
Colebunders R. et al, (2022), International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 116, 302 - 305
Evaluations of training and education interventions for improved infectious disease management in low-income and middle-income countries: a systematic literature review.
Journal article
van Dorst PWM. et al, (2022), BMJ open, 12
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Journal article
Murray CJL. et al, (2022), The Lancet, 399, 629 - 655